TargetMol

EUK-134

Product Code:
 
TAR-T6495
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6495-5mg5mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-1mL1 mL * 10 mM (in DMSO)£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-10mg10mg£108.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-25mg25mg£146.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-50mg50mg£201.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-100mg100mg£287.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-200mg200mg£406.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6495-500mg500mg£618.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
EUK 134, a synthetic superoxide dismutase (SOD)/catalase mimetic, exhibits potent antioxidant activities, and inhibits the formation of β-amyloid and related amyloid fibril.
CAS:
81065-76-1
Formula:
C18H18ClMnN2O4
Molecular Weight:
416.74
Pathway:
Neuroscience
Purity:
0.9978
SMILES:
COc1cccc2C=NCCN=Cc3cccc(OC)c3O[Mn](Cl)Oc12
Target:
Beta Amyloid

References

Bahramikia S, et al. Eur J Pharmacol. 2013, 707(1-3), 17-25. Rong Y, et al. Proc Natl Acad Sci U S A. 1999, 96(17), 19897-19902. Mohammadi M, et al. Basic Clin Pharmacol Toxicol. 2011, 108(6), 378-384. Jekabsone A, et al. J Neuroinflammation. 2006, 3, 24. Baker K, et al. J Pharmacol Exp Ther. 1998, 284(1), 215-221.